WHO ICTRP trial
Mechanism of Bone Specific Invasion of Renal Cell Carcinoma
ChiCTR2500112572 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500112572 |
|---|---|
| Public title | Mechanism of Bone Specific Invasion of Renal Cell Carcinoma |
| Scientific title | Study on The Mechanism of Bone Specific Invasion of Renal Cell Carcinoma: A Single Center, Ambispective Cohort Study |
| Primary sponsor | Peking University Third Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Renal cell carcinoma |
| Interventions | Bone Metastasis Group:None;Other Metastasis Group:None;Non-Metastasis Group:None |
| Registration date | Nov 17, 2025 |
| Target size | Bone Metastasis Group:30;Other Metastasis Group:30;Non-Metastasis Group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: